Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $100 to $102.
Wells Fargo raises Medtronic (NYSE:MDT) price target from $100 to $102 Read Post »
Oppenheimer analyst Steven Lichtman reiterates Medtronic (NYSE:MDT) with a Perform and maintains $89 price target.
Oppenheimer maintains Medtronic (NYSE:MDT) $89 price target Read Post »
Medtronic (NYSE:MDT) Raises FY24 View To Adj EPS $5.08-Adj EPS $5.16.
Medtronic (NYSE:MDT) Raises FY24 View To Adj EPS $5.08-Adj EPS $5.16. Read Post »
Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $88 to $100.
Evercore ISI raised Medtronic (NYSE:MDT) price target from $88 to $100 Read Post »
Bernstein analyst Lee Hambright maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $100 to $99.
Bernstein lowered Medtronic (NYSE:MDT) price target from $100 to $99 Read Post »
Truist Securities Adjusts Price Target on Medtronic (NYSE:MDT) to $90 From $93, Maintains Hold Rating.
Truist Securities Adjusts Price Target on Medtronic (NYSE:MDT) to $90 From $93 Read Post »
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $89 price target.
RBC Capital maintained Medtronic (NYSE:MDT) $89 price target Read Post »
UBS Downgrades Medtronic (NYSE:MDT) to Sell From Buy, Adjusts Price Target to $79 From $127
UBS Adjusts Medtronic (NYSE:MDT) Price Target to $79 From $127 Read Post »
Evercore ISI Adjusts Medtronic plc (NYSE:MDT) Price Target to $90 From $86, Maintains Outperform Rating。
Evercore ISI Adjusts Medtronic plc (NYSE:MDT) Price Target to $90 From $86 Read Post »
Feb. 21, 2023 – Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2023, which ended January 27, 2023. Q3 revenue of $7.7 billion was essentially flat year-over-year and exceeded market expectations of $7.53 billion. Non-GAAP earnings per share were $1.3, beating market expectations of $1.27. Medtronic reported third quarter worldwide revenue of $7.727 billion, a flat result as reported and an increase of 4.1% on an organic basis. GAAP diluted EPS of $0.92 decreased 16%; non-GAAP diluted EPS of $1.30 decreased 4%, ahead of expectations. Third quarter U.S. revenue of $4.062 billion represented approximately 52% of company revenue and increased 3% as reported and 2% organic. Non-U.S. developed market revenue of $2.294 billion represented 30% of company revenue and decreased 6% as reported and increased 6% organic. Emerging Markets revenue of $1.371 billion represented 18% of company revenue and decreased 1% as reported and increased
Medtronic plc (NYSE:MDT) Q3 2023 revenue of $7.727 billion Read Post »